Manufacturers should prepare for Covid-19 to be a constant in business throughout the remainder of 2020. Why? While it appears there will be numerous vaccine candidates reaching later stage clinical trials for Covid-19 in the months to come, it is unlikely they will have a significant effect on the mass population in 2020 based on the statements of numerous medical authorities. Combine this with spiking cases throughout different regions in the country and we get a recipe for a situation where things may get worse before they improve. Manufacturers need to be prepared for this scenario. Many Surplus Record readers are familiar with the general guidelines that the National Association of Manufacturers (NAM) and others have published around Covid-19. These recommendations include: engaging public officials in lobbying for key legal … [Read more...] about New Technologies and Data are Key to Preparing for Covid-19 as a “Constant” in Business Throughout 2020